Form 4: Genelux Corp Executive Ralph Smalling Reports Stock Acquisitions

Ralph Smalling, Head of Regulatory at Genelux Corp, reports acquiring common stock and restricted stock units.

Summary

• Ralph Smalling, Head of Regulatory at Genelux Corporation, filed a Form 4 detailing changes in beneficial ownership.
• On February 19, 2024, Smalling acquired 616 shares of common stock at $0 per share through restricted stock units (RSUs) that were fully vested as of February 17, 2024.
• On March 14, 2024, Smalling acquired 2,107 shares of common stock at $0 per share through RSUs that were fully vested as of March 14, 2024.
• Smalling also acquired 2,106 shares under the Issuer's Employee Stock Purchase Plan on May 16, 2024.
• Following these transactions, Smalling beneficially owns 18,144 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The acquisition of shares through RSUs and the Employee Stock Purchase Plan indicates Smalling's continued investment in Genelux Corp.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.

Key Dates